Primary Record
Isoxepac
- In stock
- 3,266 g
- Purity
- 99.7 %
- CAS
- 55453-87-7
Compound Identifiers & Properties
- CAS
- 55453-87-7
- PubChem CID
- 41448
- SMILES
- C1C2=CC=CC=C2C(=O)C3=C(O1)C=CC(=C3)CC(=O)O
- Canonical SMILES
- O=C(O)Cc1ccc2c(c1)C(=O)c1ccccc1CO2
Names & Synonyms
- Isoxepac
- 55453-87-7
- Artil
- Arelix
- Isoxepacum
- Isoxepaco
- Olopatadine related compound c
- 6,11-dihydro-11-oxo-dibenz[b,e]oxepin-2-acetic acid
- Isoxepacum [INN-Latin]
- 2-(11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid
- Artil (TN)
- HP 549
- nd4-b2
- ISOXEPAC [USAN]
- Isoxepac (USAN/INN)
- ISOXEPAC [INN]
- ISOXEPAC [MI]
- RefChem:792456
- Isoxepac [USAN:BAN:INN]
- Isoxepac [USAN:INN:BAN]
- DTXSID8057772
- HP-549
- MFCD00242952
- 6,e]oxepin-2-acetic acid
- C16H12O4
- UNII-2KH283Q0Z5
- AC1L25RP
- 2KH283Q0Z5
- SCHEMBL24970
- DTXCID9031561
- CHEMBL33211
- NSC-300907
- orb1305051
- ZINC1595
- NSC 300907
- SCHEMBL29588437
- CTK7J2356
- KS-00000HZL
- BRN 1320243
- P 720549
- 2-(11-oxo-6H-benzo[c][1]benzoxepin-2-yl)acetic acid
- CHEBI:135102
- NSC300907
- QFGMXJOBTNZHEL-UHFFFAOYSA-N
- 6,11-Dihydro-11-oxodibenz[b,e]oxepin-2-acetic acid
- GLXC-07763
- BCP12544
- CID41448
- 2-((3-Chlorophenoxy)methyl)oxirane
- Tox21_113815
- CD-627
- CI0045
- Dibenz[b, 6,11-dihydro-11-oxo-
- s5044
- AKOS015895231
- AB05479
- AC-4725
- ACN-031717
- C16-H12-O4
- CCG-267128
- EBC-118025
- FI24735
- HY-W050088
- RP29551
- P-720549
- 6,11-Dihydro-11-oxodibenz(b,e)oxepin-2-acetic acid
- Dibenz[b,e]oxepin-2-acetic acid, 6,11-dihydro-11-oxo-
- NCGC00253693-01
- (11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic acid
- AJ-08056
- AK-35631
- AN-11682
- BC209267
- BR-35631
- J11.446D
- LS-61593
- N759
- SC-13485
- SY051246
- TS-03511
- AB0016019
- CAS-55453-87-7
- DB-002606
- HP-720549
- ST2403791
- TL8003618
- TR-019548
- 11-Oxo-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid
- 4CH-017861
- CS-0031651
- D4242
- FT-0630680
- NS00033320
- P-549
- 5-18-08-00457 (Beilstein Handbook Reference)
- 6,11-DIHYDRO-11-OXODIBENZO[B,E]OXEPIN-2-ACETIC ACID
- D04638
- DIBENZ(b,e)OXEPIN-2-ACETIC ACID, 6,11-DIHYDRO-11-OXO-
- OLOPATADINE RELATED COMPOUND C [USP-RS]
- S-2236
- 453D877
- A830652
- EN300-18552809
- F036537
- 6 11-DIHYDRO-11-OXODIBENZO[B E]OXEPIN 1G
- 6 11-DIHYDRO-11-OXODIBENZO[B E]OXEPIN 5G
- 6H-11-OXODIBENZO[B,E]OXEPIN-2-ACETIC ACID
- I06-0215
- 2-(11-Oxo-6,11-dihydrodibenzo-[b,e]oxepin-2-yl)acetic acid
- 6,11-Dihydro-11-oxo-dibenz[b,e]oxepin-2-aceticacid
- 6,11-Dihydro-11-oxodibenz[b,e]oxepine-2-acetic acid
- 6,11-hydro-11-oxo-dibenz[b,e]oxepin-2-acetic acid
- BRD-K92116564-001-01-4
- OLOPATADINE RELATED COMPOUND C [USP IMPURITY]
- Q27254870
- 6,11-Dihydro-11-oxodi-benz[b,e]oxepin-2-acetic acid
- 6,11-dihydro-11-oxodibenz[b,e]oxepin-2-yl acetic acid
- Z2681893145
- (11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)acetic Acid (Isoxepac)
- 2-(11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-yl)aceticacid
- (11-Oxo-6,11-dihydro-dibenzo[b,e]oxepin-2-yl)-acetic acid
- 6,11-Dihydro-11-oxodibenzo[b,e]oxepin-2-acetic acid =97.0% (by HPLC, titration analysis)
- {2-oxo-9-oxatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-yl}acetic acid
- 2-{2-oxo-9-oxatricyclo[9.4.0.0(3),?]pentadeca-1(15),3,5,7,11,13-hexaen-5-yl}acetic acid
- 2-{2-oxo-9-oxatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,11,13-hexaen-5-yl}acetic acid
- 2-{2-oxo-9-oxatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-5-yl}acetic acid
- 2-{2-oxo-9-oxatricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaen-5-yl}acetic acid
- 26250-84-0
- 6,11-Dihydro-11-oxodibenz[b,e]oxepin-2-acetic acid; 11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-acetic acid; 11-Oxo-6,11-dihydrodibenz[b,e]oxepin-2-acetic acid; 11-Oxo-6,11-dihydrodibenzo[b,e]oxepin-2-acetic acid; 6,11-Dihydro-11-oxodibenz[b,e]oxepin-2-acetic acid; Artil; HP 549; Isoxepac; NSC 300907; P 720549; Dibenz[b,e]oxepin-2-acetic acid, 6,11-dihydro-11-oxo-; Olopatadine Related Compound C